Zobrazeno 1 - 10
of 56
pro vyhledávání: '"HITOSHI KOJO"'
Autor:
Hitoshi Kojo, Masao Fukagawa, Kaoru Tajima, Akiko Suzuki, Takao Fujimura, Ichiro Aramori, Ken-ichi Hayashi, Shintaro Nishimura
Publikováno v:
Journal of Pharmacological Sciences, Vol 93, Iss 3, Pp 347-355 (2003)
ABSTRACT: The nuclear receptor PPAR (peroxisome proliferator-activated receptor) has three subtypes named α, δ(β), and γ that may act as receptors for a range of compounds including antihyperglycaemic drugs, insulin sensitizers, and non-steroidal
Externí odkaz:
https://doaj.org/article/143313b742014705beb6f954d5c8a6c8
Publikováno v:
Chem-Bio Informatics Journal. 16:13-24
Autor:
Kiyoshi Aita, Dobun Hayashi, Hideyuki Koide, Kenichi Sato, Hitoshi Kojo, Tsugumi Okuzawa, Tetsuro Nakamura, Wakako Suhara, Satoru Nakano
Publikováno v:
Journal of Food Biochemistry. 35:776-791
A saponin-enriched soybean extract was tested for agonistic activities against a series of nuclear receptors including peroxisome proliferator-activated receptors (PPARs) and cholesterol metabolism-related, retinoid-related, hormone-related and detox
Publikováno v:
Biochemical Pharmacology. 71:1184-1197
Adipocyte dysfunction is strongly associated with the development of obesity and insulin resistance. It is accepted that the regulation of adipocytokine secretion or the adipocyte specific gene expression is one of the most important targets for the
Autor:
Shigeki Satoh, Hiroe Sawai, Hitoshi Kojo, Noriyuki Morikawa, Teruo Oku, Yoshitada Notsu, Tsuyoshi Mizutani, Noriaki Inamura, Ichiro Aramori, Yuki Sawada, Chie Hatori, Yoshito Abe, Hiroshi Kayakiri, Takayuki Inoue, Masayuki Asano, Junko Zenkoh, Kunio Nakahara
Publikováno v:
Molecular Pharmacology. 52:16-20
Kinins, members of a family of peptides released from kininogens by the action of kallikreins, exhibit a variety of biological activities including vasodilation, increased vascular permeability, contraction of smooth muscle cells, and activation of s
Autor:
Yoshitada Notsu, Jiro Hirosumi, Satoru Takahashi, Osamu Nakayama, Kozo Sawada, Hitoshi Kojo, Noboru Chida
Publikováno v:
The Prostate. 31:241-249
BACKGROUND Steroid 5α-reductase is implicated in the pathogenesis of benign prostatic hyperplasia (BPH). We studied the in vitro and in vivo effects of FR146687, a new inhibitor of 5α-reductase. METHODS Two isozymes of rat and human 5α-reductases
Autor:
Hitoshi Kojo, Junko Zenkoh, Ichiro Aramori, Morita Iwami, Kozo Nakamura, Masayuki Asano, Noriyuki Morikawa, Nuala O’Donnell, Yoshitada Notsu
Publikováno v:
Molecular Pharmacology. 51:171-176
We describe the receptor binding and antagonistic properties of two novel nonpeptide antagonists, FR167344 (3-bromo-8-[2,6-dichloro-3-[ N -[( E )-4-( N , N -dimethylcarbamoyl)cinnamidoacetyl]- N -methylamino]benzyloxy]-2-methylimidazo[1,2-a]pyridine
Publikováno v:
PAIN RESEARCH. 12:131-137
Publikováno v:
PAIN RESEARCH. 12:15-19
Autor:
M. Okuhara, O. Nakayama, M. Inami, Y. Notsu, S. Takahashi, K. Sawada, Hitoshi Kojo, J. Hirosumi, T. Fagan, N. Chida
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 52:357-363
Steroid 5 alpha-reductase is an enzyme which converts testosterone into 5 alpha-dihydrotestosterone (DHT) and is implicated in the pathogenesis of benign prostatic hyperplasia (BPH) in men. We studied in vitro effects of FK143, a nonsteroidal new com